Screening Strategies in Drug Discovery – Products

Ziath offer a complete OEM design, development and supply service based upon its extensive experience of creating high performance 2D barcoded tube scanners and rack readers for biobanking, compound library, pathology and COVID-19 sample management applications.

BellBrook Labs has been awarded a $1.8 million Phase II SBIR grant for the treatment of lupus and other autoimmune diseases.

Access this whitepaper to discover a system that performs virtual screening at ultra-high-throughput scale, requires minimal costs and can be run with cloud computing or HPC resources.

Repositive has announced that Vivan Therapeutics will be the next company to join its global network of cancer model partners. With this new partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers in their oncology drug development programs.

PerkinElmer recently launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents works alongside the Company’s microplates, automation, software and high-content screening instruments.

Download this app note to discover an example that shows pooling crRNAs to the same gene target provides robust functional knockout and reveal ways to ensure crRNA pools work successfully in phenotypic screening.

Built on the success of the company’s flagship model, the ImageXpress® Confocal HT.ai High-Content Imaging System is designed to help researchers advance phenotypic screening of 3D organoid models.

Download this app note to learn more about automated patch clamp and the benefits of using it in drug discovery.